News - Rest of the World, Teva Pharmaceutical Industries

Filter

Popular Filters

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

05-12-2013

Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Teva Pharma reaches $718 million tax settlement with Israel State

Teva Pharma reaches $718 million tax settlement with Israel State

12-11-2013

Israel-headquartered global generic drug giant Teva Pharmaceutical Industries has reached an agreement…

FinancialGenericsRest of the WorldTeva Pharmaceutical Industries

Teva results report increase in sales despite flat generic revenues

Teva results report increase in sales despite flat generic revenues

01-11-2013

Still shaken by the sudden resignation of its chief executive this week, Israel-based Teva Pharmaceutical…

FinancialGenericsRest of the WorldTeva Pharmaceutical Industries

Teva and Lonza to discontinue their biosimilars collaboration

25-07-2013

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Galena Biopharma leaps on deal with Teva for NeuVax in Israel

05-12-2012

Shares of US biotech firm Galena Biopharma (Nasdaq: GALE) leapt 13.7% to $2.32 in pre-market trading…

BiotechnologyGalena BioPharmaLicensingnelipepimut-SNeuVaxOncologyRest of the WorldTeva Pharmaceutical IndustriesVaccines

Teva gets rights to BioAlliance's Sitavig in Israel

14-06-2012

French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has signed an exclusive license agreement for…

Anti-viralsBioAlliance PharmaLicensingPharmaceuticalRest of the WorldSitavigTeva Pharmaceutical Industries

Acino pays 80 million euros for Cephalon’s Middle East and African business

18-10-2011

Switzerland-based generic and branded drugmaker Acino (SIX: ACIN) says it has reached agreement to acquire…

Acino PharmaCephalonGenericsMergers & AcquisitionsPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Back to top